Product Information
IBUPROFEN 200 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0329 per EA under NDC 49483060101. Its NADAC has been published 509 times since Nov 23, 2016.
FDA first approved this application on Feb 1, 2011.
Strength
200 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483060101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA091239FDA Approved
2/1/2011
On Market Since
3/22/2016
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 200 MG TABLET has been published 509 times since Nov 23, 2016, and over the history we have for it it has risen 19.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0329 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0250 (Jul 19, 2017) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0329 |
| Average price | $0.0322 |
| Largest weekly change | -15.1% (Jul 19, 2017) |
| Weeks tracked | 509 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the IBUPROFEN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0329 per EA (NDC 49483060101), effective Aug 19, 2026.
How has the price of IBUPROFEN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 200 MG TABLET has risen 19.3%. It has been tracked across 509 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG TABLET?
Since Nov 23, 2016, the NADAC for IBUPROFEN 200 MG TABLET has ranged from a low of $0.0250 (Jul 19, 2017) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0329 per EA.
Are there cheaper alternatives to IBUPROFEN 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of IBUPROFEN 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures IBUPROFEN 200 MG TABLET?
IBUPROFEN 200 MG TABLET (NDC 49483060101) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.